Heerspink HJL, Karasik A, Thuresson M, Melzer-Cohen C, Chodick G, Khunti K, et al
All components in the KLOW Blend are manufactured to high-purity research standards and supplied as LPS-free peptides
The major generics are Noveltreat/Sematrinity (Sun Pharma), Obeda/Usema (Dr Reddy's + USV), Semaglyn/Mashema/Alterme (Zydus), Semanext/Livarise (Lupin via Zydus), Semasize/Obesema/Hepaglide (Alkem), GLIPIQ (Glenmark), Sembolic/Semalix (Torrent injectable + oral), Semabest (MSN Labs first integrated made-in-India semaglutide, April 2026 launch), SUNDAE/Semanat/Semafull (Eris/Natco), and Samakind (Mankind)
Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study
A Bitter Pill for Type 2 Diabetes
Extracellular vesicles and intercellular communication: challenges for in vivo molecular imaging and tracking